MedPath

Effect of Ascorbic Acid on Postoperative Pulmonary Complications in Patients Undergoing Cardiac Surgery

Early Phase 1
Conditions
Postoperative Pulmonary Complications
Interventions
Registration Number
NCT03756727
Lead Sponsor
Xuzhou Medical University
Brief Summary

Postoperative pulmonary complications(PPCs) including, but not limited to ,hypoxemia, pneumonia, ventilator-induced lung injury, and acute respiratory distress syndrome (ARDS),atelectasis,pleural effusion .PPCs may result in increased resources utilization, delayed mobilization, prolonged need of supplemental oxygen or mechanical ventilation,and a longer hospital stay.postoperative pulmonary complications are common after cardiac surgery, often increasing postoperative morbidity and mortality.The extracorporeal circulation,increased oxygen concentration inhaled and the development of massive atelectasis after open-chest surgery commonly activate lung inflammation, amplifying the harm Injury of pulmonary .Currently, plenty of interventions have been studied to prevent PPCs after surgery. Most of the recent research has focused on physical therapy such as lung-protective modes during intraoperative mechanical ventilation, Alveolar Recruitment, and respiratory muscle training.These therapies have a certain effect, but still not satisfactory.Ascorbic acid is an important cofactor in multiple enzymatic reactions where its main function is as a reducing agent.Studies have shown that ascorbic acid can reduce both ischemia-reperfusion injury and oxidative stress. Unfortunately, no studies examined whether Ascorbic acid can reduce PPCs.

Detailed Description

The possible mechanisms of ascorbic acid to alleviate ischemia-reperfusion injury are as follows: 1 Ascorbic acid as a first-line antioxidant in plasma can reduce stress by eliminating excess Reactive oxygen species and reduce damage. 2 provides rapid electron transfer to react with superoxide and hydroxyl group to scavenge reactive oxygen released into the circulation. 3 Ascorbic acid can reduce lipid peroxidation and reduce lung injury caused by ischemia-reperfusion by scavenging oxygen free radicals. 4 Vitamin C can promote the production of cytokines by immune cells to reduce local inflammatory reactions and improve tissue microcirculation.The study aims to explore whether daily used Ascorbic acid in the perioperative period has a preventive effect on PPCs in patients undergoing cardiac surgery, and through short-term and long-term follow-up, to investigate the effect on post-hospitalization Prognosis .

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
110
Inclusion Criteria
  1. Age between 18-60 years old
  2. Selective cardiac surgery under cardiopulmonary bypass
Exclusion Criteria
  1. Emergency surgery
  2. Previous cardiac surgery
  3. Severe lung disease
  4. BMI<18 or >30
  5. Mean pulmonary arterial pressure >40 mmHg
  6. were allergic to ascorbic acid

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control comparator groupSalinethe patients received 10ml saline at the night before surgery, during the surgery and five days after surgery.
Ascorbic acid groupAscorbic Acidthe patients received 2g of intravenous Ascorbic acid at the night before surgery, during the surgery and five days after surgery.
Primary Outcome Measures
NameTimeMethod
severity of postoperative pulmonary complicationsan average of 2 weeks

Use the postoperative pulmonary complications score to record the severity. scored ranging from 0 to 5.Scored the severity once a day, record the highest score.

Secondary Outcome Measures
NameTimeMethod
incidence of postoperative pulmonary complicationsan average of 10 days

incidence of postoperative pulmonary complications during hospital stay

extubation and wake timean average of 1 day

length of extubation time,length of wake time

length of ICU stay and length of hospital stayan average of 10 days

all patients transfer to ICU after surgery

PaO2/FiO21 day, 3 days,5 days post surgery

Oxygenation index (PaO2/FiO2) in millimeter mercury column.

A-aDO21 day, 3 days,5 days post surgery

alveolar-arterial oxygen tension difference (A-aDO2)

positive end expiratory pressurean average of 1 day

positive end expiratory pressure in centimeter water column

Plateau pressurean average of 1 day

Plateau pressure in centimeter water column

Peak airway pressurean average of 1 day

Peak airway pressure in centimeter water column

post-hospitalization follow-uponce a day till 30 days post-hospitalization

record the incidence of postoperative pulmonary complications after hospital discharged.

lung compliancean average of 1 day

lung compliance in Milliliter/ centimeter water column

Trial Locations

Locations (1)

The Affiliated Hospital of Xuzhou Medical University

🇨🇳

Xuzhou, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath